Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Advances in Therapy|April 29, 2005
The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertensionRichard Quinones, Melissa L EarlOphthalmology|February 5, 2002
Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure loweringSteven T Simmons, Melissa L Earl, Advances in Therapy|March 21, 2008
A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertensionWilliam Trattler, Robert J Noecker, Melissa L EarlDermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 20, 2003
Social implications of hyperfunctional facial linesJ Charles Finn, Sue Ellen Cox, Melissa L EarlThe CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|June 11, 2002
A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patientsJulie M Albietz, Lee M Lenton, Sue G McLennan, et al.Advances in Therapy|July 3, 2003
Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertensionRobert J Noecker, Melissa L Earl, Tom Mundorf, et al.Current Medical Research and Opinion|November 2, 2006
Comparing bimatoprost and travoprost in black AmericansRobert J Noecker, Melissa L Earl, Thomas K Mundorf, et al.Pageof 1